Home > EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’).

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA–Europol Joint Report on ‘MT-45’)
358kB

In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on MT-45 as stipulated by Article 5.1 of the Council Decision.

Table of contents:
• Introduction
• Information collection process
• Information required by Article 5.2 of the Council Decision
• Information from the EMA (Article 5.3 of the Council Decision)
• Conclusion
• References
• Annexes


Item Type
Report
Date
2014
Pages
17 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction, Europol
Place of Publication
Luxembourg
ISBN
978-92-9168-745-9
EndNote
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page